References
- Li G, Thabane L, Papaioannou A, Ioannidis G, Levine MA, Adachi JD. An overview of osteoporosis and frailty in the elderly. BMC Musculoskelet Disord 2017;18:46
- Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010;17:25–54
- Compston J. Osteoporosis: advances in risk assessment and management. Clin Med (Lond) 2016;16:S121–S124
- Weaver CM, Gordon CM, Janz KF, et al. The National Osteoporosis Foundation’s position statement on peak bone mass development lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int 2016;27:1281–386
- Wood CL, Stenson C, Embleton N. The developmental origins of osteoporosis. Curr Genomics 2015;16:411–18
- Camargo MB, Cendoroglo MS, Ramos LR, et al. Bone mineral density and osteoporosis among a predominantely caucasian elderly population in the city of São Paulo, Brazil. Osteoporos Int 2005;16:1451–60
- Martini LA, Moura EC, Santos LC, Malta DC, Pinheiro Mde M. Prevalence of self-reported diagnosis of osteoporosis in Brazil, 2006. Rev Saude Publica 2009;43:107–16
- Baccaro LF, Conde DM, Costa-Paiva L, Pinto-Neto AM. The epidemiology and management of postmenopausal osteoporosis: viewpoint from Brazil. Clin Interv Aging 2015;10:583–91
- United Nations. World Population Ageing. United Nations, p. 46. 2017
- Rodrigues IG, Barros MB. Osteoporosis self-reported in the elderly: a population-based survey in the city of Campinas, São Paulo, Brazil. Rev Bras Epidemiol 2016;19:294–306
- Compston J, Cooper A, Cooper C, National Osteoporosis Guideline Group (NOGG), et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 2017;12:43
- Upala S, Sanguankeo A, Congrete S. Association between obstructive sleep apnea and osteoporosis: a systematic review and meta-analysis. Int J Endocrinol Metab 2016;14:e36317
- Tan LJ, Wang ZE, Wu KH, et al. Bivariate genome-wide association study implicates ATP6V1G1 as a novel pleiotropic lócus underlying osteoporosis and age at menarche. J Clin Endocrinol Metab 2015;100:E1457–1466
- Miyamoto T. Mechanism underlying post-menopausal osteoporosis: HIF1α is required for osteoclast activation by estrogen deficiency. Keio J Med 2015;64:44–7
- Sapir-Koren R, Livshits G. Postmenopausal osteoporosis in rheumatoid arthritis: the estrogen deficiency-immune mechanisms link. Bone 2017;103:102–15
- Wu G, Xu R, Zhang P, et al. Estrogen regulates stemness and senescence of bone marrow stromal cells to prevent osteoporosis via ERβ-SATB2 pathway. J Cell Physiol 2018;233:4194–204
- Kanis J. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002;359:1929–36
- Pinheiro MM, Reis Neto ET, Machado FS, et al. Risck factors for osteoporotic fractures and low boné density in pré and postmenopausal women. Rev Saúde Pública 2010;44:479–85
- Curtis JR, McClure LA, Delzell E, et al. Population based fracture risk assisment and osteoporosis treatment disparites by race and gender. J Gen Intern Med 2009;24:956–62
- Looker AC, Sarafrazi Isfahani N, Fan B, Shepherd JA. FRAX-based estimates of 10-year probability of hip and major osteoporotic fracture among adults aged 40 and over: United States, 2013 and 2014. Natl Health Stat Report 2017;103:1–16
- Cavalli L, Guazzini A, Cianferotti L, et al. Prevalence of osteoporosis in the Italian population and main risk factors: results of the bone tour campagne. BMC Musculoskelet Disord 2016;17:396
- Bijelic R, Milicevic S, Balaban J. Risk factors for osteoporosis in postmenopausal women. Med Arch 2017;71:25–8
- Kakehasi AM, Carvalho AV, Maksud FA, Barbosa AJ. Serum levels of vitamin B12 are not related to low bone mineral density in postmenopausal Brazilian women. Rev Bras Reumatol 2012;52:863–9
- Mazocco L, Chagas P. Association between body mass index and osteoporosis in women from northwestern Rio Grande do Sul. Rev Bras Reumatol Engl Ed 2017;57:299–305
- Silva TR, Franz R, Maturana MA, Spritzer PM. Association between body composition and lifestyle factors with bone mineral density according to time since menopause in women from southern Brazil: a cross-sectional study. BMC Endocr Disord 2015;15:71
- Yoldemir T, Erenus M, Durmusoglu F. The impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopause. Gynecol Endocrinol 2012;28:884–8
- Qiu C, Chen H, Wen J, et al. Association between age at menarche and menopause with cardiovascular disease, diabetes and osteoporosis in Chinese women. J Clin Endocrinol Metab 2013;98:1612–21
- Zhao L, Cui B, Liu JM, et al. Interactions of osteoporosis candidate genes for age at menarche, age at natural menopause and maximal height in Han Chinese women. Menopause 2011;18:1018–25
- Sioka C, Fotopoulos A, Georgiou A, Xourgia X, Papadopoulos A, Kalef-Ezra JA. Age at menarche, age at menopause and duration of fertility as risk factors for osteoporosis. Climacteric 2010;13:63–71
- Akdeniz N, Akpolat V, Kale A, Erdemoglu M, Kuyumcuoglu U, Celik Y. Risk factors for postmenopausal osteoporosis: anthropometric measurements, age, age at menopause and the time elapsed after menopause onset. Gynecol Endocrinol 2009;25:125–9
- Chen P, Li Z, Hu Y. Prevalence of osteoporosis in China: a meta-analysis and systematic review. BMC Public Health 2016;16:1039